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ABSTRACT 
Endometriosis is defined by presence of endometrial-like-tissue outside the uterus. Recently, ectopic endometriotic 
lesions have been suggested to originate by abnormal differentiation of endometrial mesenchymal stem cells (eM-
SCs). MicroRNAs (miRNAs) play an important role in the pathophysiology of endometriosis. Through a PCR 
array approach, we aimed to assess the differential expression of microRNAs in human eMSC treated in culture 
with sera derived from women with severe endometriosis. Sera were collected from five patients with severe en-
dometriosis and three control women and added individually in the culture medium to conduct experimental and 
control eMSC sets, respectively. Regular microscopic follow-up for cell morphology was performed. SYBR Green 
based real-time PCR array was used to assess the expression of 84 miRNAs. Bioinformatics analysis was done to 
predict the target genes of the significantly dysregulated miRNAs and their enriched biological processes and 
pathways. Thirty-two miRNAs were found significantly dysregulated in experimental cultures. Functional enrich-
ment analysis revealed several endometriosis associated biological processes and pathways were enriched by target 
genes of these miRNAs. In conclusion, treatment of human eMSCs with sera of severe endometriosis cases affects 
the expression of certain miRNAs and their target genes. This may result in altering cell functions and conse-
quently, endometriosis development. 
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INTRODUCTION 
Endometriosis is an inflammatory disor-
der, characterized by the presence of endome-
trial-like-tissue outside the uterus in pelvic or 
extra pelvic locations. It affects about 6 to 
10 % of reproductive aged-women and is as-
sociated with chronic pelvic pain and infertil-
ity (Giudice, 2010). Although an endometri-
otic implant is a benign tissue, it shares cer-
tain characteristics with cancer such as cell 
migration, adhesion, invasion, matrix remod-
eling, proliferation, survival, angiogenesis 
promotion, and escaping immune surveil-
lance (Burney and Giudice, 2012). Several 
theories have been introduced to explain en-
dometriosis etiology (Maruyama, 2014), 
however, they are still not fully confirmed 
(Sourial and Tempest, 2014). Improving 
knowledge on endometriosis pathogenesis 
may assist in identifying novel targets for for-
mulating more effective therapies (Sourial 
and Tempest, 2014).  
Since the discovery of endometrial 
stem/progenitor cells, accumulating evi-
dences have been provided for the involve-
ment of these undifferentiated cells in endo-
metriosis development (Sasson and Taylor, 
2008). 
Among the endometrial progenitors that 
have been identified are mesenchymal 
stem/stromal cells (MSCs) (Gargett et al., 
2009). MSCs are clonogenic fibroblast like 
cells that have the potential to self-renew and 
differentiate into multiple lineages (Gargett et 
al., 2016). A number of investigators revealed 
that ectopic implants-derived MSCs had en-
hanced proliferation, migration, invasion and 
angiogenic abilities, over eutopic counter-
parts, proposing that endometrial MSCs may 
be one of stem cells which participate in en-
dometriosis progression (Kao et al., 2011; 
Hsu et al., 2014).  
MicroRNAs (miRNAs) act as post-tran-
scriptional gene expression regulators 
(Macfarlane and Murphy, 2010). miRNAs 
play essential roles in nearly all biological and 
pathological processes in the human body (Ha 
and Kim, 2014). Among the various patholog-
ical conditions in which miRNAs take part, 
are gynecological and fertility disorders 
(Gilabert-Estelles et al., 2012). In this context, 
several studies have revealed that aberrant ex-
pression of miRNAs has a direct potential role 
in the pathogenesis of endometriosis (Pan et 
al., 2007; Ohlsson Teague et al., 2009; 
Filigheddu et al., 2010; Hawkins et al., 2011). 
miRNAs are key candidates in regulating cell 
fate through controlling different cellular bio-
logical processes as proliferation, apoptosis 
and differentiation. Accordingly, miRNAs 
were found to be the main actors in stem cell 
development and commitment (Mathieu and 
Ruohola-Baker, 2013).  
Earlier, our group demonstrated that cul-
ture of human MSCs (hMSCs) with serum de-
rived from moderate and severe endometrio-
sis cases had induced morphological and mo-
lecular changes providing evidence that se-
rum of women with endometriosis harbors a 
possible endometriosis inducing factor(s) 
(EIF) that enables the MSCs to acquire the 
phenotype of endometrial-like-cells in vitro 
(Rasheed et al., 2010, Azmy et al., 2014). 
Later on, by assessing the differential ex-
pression of 84 miRNAs in the sera of severe 
endometriosis cases, we suggested that miR-
130a may be EIF mediates the trans-differen-
tiation of MSCs into endometrial-like cells, in 
addition to regulating gene expression in sev-
eral endometriosis related biological pro-
cesses and cell functions (Azmy and Elgarf, 
2012; Azmy et al., 2014). 
 
MATERIALS AND METHODS 
Study population 
This study represents an experimental 
prospective case-control pilot study, includ-
ing eight women subjects. It was approved by 
the Medical Research Ethics Committee of 
the National Research Centre, Cairo, Egypt, 
under registration number 12-002. Written in-
formed consents were obtained from all par-
ticipants to collect samples as well as to pub-
lish the results.  
The samples were recruited from the Ob-
stetrics and Gynecology Department, Faculty 
of Medicine, Cairo University. The enrolled 
women in the study met the following criteria; 
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they suffered from infertility and/or pain and 
underwent laparoscopy for diagnosis, they did 
not receive any hormonal therapy 6 months 
prior to the time of sample collection, they did 
not have a history of blood malignancies, 
chronic or immunological diseases. Of the 
eight participants, five had severe endometri-
osis (the experimental group) and three were 
endometriosis free (the control group). The 
severity of the disease was clinically identi-
fied according to the revised American Soci-
ety of Reproductive Medicine staging system 
(rASRM, 1997). Endometriosis laparoscopic 
diagnosis was confirmed by histopathological 
examination, while, the laparoscopy inspec-
tion in control subjects showed that they were 
clearly free from any endometriotic lesions.  
 
Serum collection 
Peripheral blood samples were collected 
from patients (n=5), and control (n=3). Whole 
blood was drained into vacutainer without an-
ticoagulants and allowed to clot overnight at 
4 °C. Serum was aliquoted and separated by 
centrifugation at 2.000 rpm for 15 min. Sub-
sequently the supernatant was aliquoted and 
frozen at -20 °C.  
 
Tissue collection 
Specimens of endometrial tissues were 
collected under sterile conditions from 
women suffering from dysfunctional uterine 
bleeding undergoing curettage as a treatment 
of choice in severe cases, in the operating the-
atre room. Part of the endometrial tissues 
were sent to pathological examination and the 
rest of specimens were immediately placed in 
DMEM low glucose media containing antibi-
otic/antifungal mix to be further processed for 
mesenchymal stromal cell isolation within 
two hours of procurement. Endometrial tis-
sues with pathological conditions were dis-
carded. 
 
Isolation and culture of endometrial  
mesenchymal stromal cells  
As previously reported (Kao et al., 2011), 
the collected endometrial tissue samples were 
enzymatically digested to drive the tissue 
mononuclear cells which were cultured in 
DMEM low glucose medium (Lonza) supple-
mented with 10 % FBS, 100 units/ml penicil-
lin (Gibco), 100 μg/ml streptomycin (Pen-
Strep, Lonza) and 2 mM/L glutamax (Gibco). 
The cultures were then incubated in humidi-
fied atmosphere with 5 % CO2 concentration 
in CO2 incubator (Sartorius Stedim Biotech, 
GmbH, Germany). Media exchange was done 
every 2-3 days. After attaining confluence, 
the cultures underwent subsequent passaging 
until passage 3. 
 
Cell culture treatment 
At the third passage, thirty percent conflu-
ent eMSC cultures were challenged with the 
previously collected sera. To conduct experi-
mental and control cultures, five endometri-
otic and three control serum samples were 
added, separately, to the regular growth me-
dium with a final serum concentration (5 %) 
respectively. An experimental or a control 
culture was fed once per 2 weeks with the me-
dia containing the corresponding serum sam-
ple for a period of 8 weeks.  
 
Microscopic follow up and  
photo-documentation 
The morphology of cultured MSCs was 
examined periodically under inverted micro-
scope (Nikon eclipse TS 100, Japan) and was 
photographed using digital eyepiece camera 
(Premiere, MA 88-500). 
 
MicroRNAs expression analysis 
RNA extraction and cDNA synthesis 
Total RNA was isolated from cell cultures 
with the mirVana miRNA Isolation Kit (Am-
bion, USA) according to the manufacturer’s 
protocol. RNA purity and concentration were 
measured using a NanoDrop ND-2000 spec-
trophotometer (Thermo Scientific, USA). 
Then, RNA was reverse transcribed to cDNA 
using a Superscript II First Strand Synthesis 
System (Qiagen). Each reverse transcriptase 
(RT) reaction contained 125-250 ng of RNA 
sample, 2 µl of 10x miScript Nucleic Mix, 
10x miScript Reverse Transcriptase mix, and 
4 µl 5× miScript HiSpec Buffer (all included 
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in First-strand cDNA synthesis kit), with total 
volume of 20 µl. Reactions were incubated in 
a thermal cycler (Applied Biosystem) for 60 
minutes at 37° C, followed by a heat-inactiva-
tion step for 5 minutes at 95° C and held at 4° 
C. 
 
MicroRNA real time polymerase chain  
reaction 
The expression levels of a panel of 84 
miRNAs were assessed using an SYBR 
Green-based miScript miRNA PCR array 
(Human miFinder miRNA PCR Array: 
MIHS-001Z, Qiagen). The analyzed miRNAs 
are a group of 84 most abundantly expressed 
and well characterized miRNAs in miRBase 
(http://www.miRBase.org). Three control 
sets were present in this panel; the first con-
tained six miRNAs (snoRNA/snRNA) whose 
average of readings enables normalization of 
the array data using the relative quantification 
method, the second was for assessing the per-
formance of reverse transcription reaction and 
the third was for assuring PCR performance.  
Reaction mixture for pathway-focused 
miScript miRNA PCR array was prepared ac-
cording to manufacturer’s instructions (Qi-
agen). Quantitative real-time PCR (qPCR) 
analysis was performed in an ABI 7500 De-
tection System (Applied Biosystems). The 
thermal conditions for qPCR were as follows: 
initial activation step at 95 °C for 15 minutes, 
50 cycles of denaturation at 94 °C for 15 sec-
onds followed by an annealing step at 55 °C 
for 30 seconds, then extension step at 70 °C 
for 30 seconds. Relative miRNA expression 
was calculated using the 2-ΔΔCt method (Livak 
and Schmittgen, 2001). All experiments were 
performed on two different endometrial MSC 
lines. 
 
Statistical analysis 
Data were expressed as mean ± standard 
error. Statistical differences between means 
of experimental and control groups were ana-
lyzed using unpaired Student’s t-test. P values 
less than 0.05 was considered statistically sig-
nificant. Statistical analysis was carried out 
using the SPSS 16.0 software (IBM, New 
York, USA). 
 
Bioinformatics analysis 
Computational prediction of miRNA tar-
gets is an important step for exploring the 
miRNA-mRNA interactions. We identified 
the in silico predicted and validated targets of 
the significantly differentially expressed 
miRNAs and performed the functional en-
richment analysis of these targets using differ-
ent bioinformatics tools. Our workflow is 
shown in Figure 1.
 
 
Figure 1: A flow chart illustrating our computational miRNA target prediction and functional analysis 
steps
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MicroRNA computational target analysis 
MicroRNA target analysis was done by 
two parallel protocols: combinatorial miRNA 
target analysis; where target prediction was 
performed for a whole defined miRNA set, 
and collective miRNA target analysis, where 
target analysis was performed for each 
miRNA in a defined set followed by integrat-
ing the obtained targets for functional and 
pathway enrichment. 
Combinatorial Method: Combinatorial 
analysis was performed using the bioinfor-
matics tool; miRror Suite 2.0 
[http://www.proto.cs.huji.ac.il/mirror/].  
Collective Method: Predicted and vali-
dated target genes of an individual miRNA of 
our differentially expressed miRNAs were 
derived using miRWalk 2.0 server [http://mir-
walk.uni-hd.de/].  
 
Functional annotation enrichment  
analysis 
For both combinatorial and collective 
methods, the functions of the obtained 
miRNA target genes and the pathways in 
which they could be involved were analyzed 
using the DAVID server (Database for Anno-
tation, Visualization and Integrated Discov-
ery), [https://david.ncifcrf.gov]. It identifies 
the enriched gene ontology terms and path-
ways from KEGG, Biocarta, Panther, Reac-
tome, and others to help finding out the most 
relevant functions associated with a given 
gene list (Dennis et al., 2003, Huang da et al., 
2009). For the combinatorial method, target 
genes were also submitted to FunRich 2.1.1 
(Functional enrichment analysis tool for bio-
logical processes and pathways analysis) 
[http://funrich.org/index.html]. It is stand-
alone functional enrichment analysis software 
that permits offline data analysis on the user’s 
desktop (Pathan et al., 2015). The key en-
riched pathways and gene ontology annota-
tions, which were suggested to be associated 
with endometriosis, were then investigated. 
 
RESULTS 
In the present work, stroma of endometri-
osis free endometria were used as a source for 
MSCs. A sub-confluent eMSC culture at pas-
sage (3) was challenged with either an endo-
metriotic or a non-endometriotic serum. Two 
main eMSC culture sets were established: ex-
perimental set; endometriotic serum treated 
cultures (n=5) and the control set; non-endo-
metriotic serum treated cultures (n=3). The 
two sets were studied in terms of morpholog-
ical changes and expression profile of 84 
miRNAs using a SYBR Green-based real-
time PCR array.  
 
Microscopic follow up for the morphologi-
cal characteristics of eMSC cultures during 
the expansion/proliferation phase 
Endometrial mesenchymal stromal cells 
were isolated and cultured as described in ma-
terials and methods. The morphology of eM-
SCs that were cultured in the regular growth 
medium, before serum challenge, is shown in 
Figure 2. Plastic adherent short spindle fibro-
blast like cells appeared in the culture flasks 
after a few days of incubation. After a week, 
the cells gradually grew to form small colo-
nies (Figure 2A). As growth continued, colo-
nies gradually expanded in size and the adja-
cent ones became interconnected (Figure 2B). 
These primary cells formed a confluent mon-
olayer after 10–12 days of initial plating (Fig-
ure 2C). By subsequent passaging, homoge-
nous confluent layer of elongated spindle fi-
broblast like cells predominated (Figure 2D). 
 
Morphological and growth characteristics 
of eMSCs during the serum challenge 
phase 
It was observed that cell proliferation and 
morphology in the experimental cultures, 
treated with endometriotic sera, had changed 
gradually by time, compared to those treated 
with non-endometriotic sera (Figure 3). 
Within the first two weeks of challenge, the 
experimental cultures showed maintained 
proliferation and fibroblastic morphology 
(Figure 3C and D). At later weeks, various 
morphological changes appeared associated 
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with moderate to high decrease in cell growth 
and proliferation among experimental cul-
tures compared to control cultures (Figure 
3E). Shrinkage of fibroblastic like- cells of 
some experimental cultures was observed 
(Figure 3F), while other cultures kept the fi-
broblastic morphology (Figure 3G); with oc-
casional appearance of irregular cell morphol-
ogies in some areas (Figure 3H). 
 
 
Figure 2: Microscopic follow-up for morphological 
characteristics and proliferation performance of 
eMSC cultures during expansion phase 
(A) Shows a small colony of short spindle cells at 
day 7 of primary culture, which by continuous 
growth, increased in size to fuse with an adjacent 
colony, shown in (B), forming a confluent mono-
layer of fibroblastic eMSCs at the end of P0 (C). 
(D, E, and F) Show confluent monolayer of eM-
SCs at the end of passage (2). The arrow points 
to the fibroblastic morphology. Magnification 
power X40 
 
 
 
Figure 3: Microscopic follow-up for morphological characteristics and proliferation performance of 
eMSC cultures during serum challenge phase.  
(A) Shows eMSC culture at passage 3 just before serum application. (B) Shows control serum treated 
eMSC culture with fibroblastic morphology and enhanced proliferation at the second week of serum 
incubation. (C and D) are representative photos for the experimental cultures within the first two weeks 
of serum addition. They show relatively maintained fibroblastic morphology and cell proliferation. (E) 
Shows control culture with typical spindle morphology and maintained proliferation capacity at the sixth 
week of serum addition. (F) Shows an obvious decline in cell growth and proliferation accompanied with 
cell shrinkage in some experimental eMSC cultures, at week 6 of endometriotic serum challenge. (G) 
Shows lesser decrease in cell proliferation and predominant fibroblastic morphology in other eMSC cul-
tures at week 6 of endometriotic serum addition, however, irregular morphologies appeared occasionally 
in some fields, as indicated by arrows (H). Magnification power X40
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MicroRNA expression analysis 
Using miFinder miRNA PCR Array plat-
form, the expression profile of 84 miRNAs 
was assessed for the control and experimental 
cultures. Data were presented as fold-change 
relative to the control group. The average cy-
cle threshold of six miRNAs; hsa-mir-101-3p, 
122-5p, 141-3p, 142-5p, 302b-3p, and 9-5p 
were greater than the defined cut-off value 
(default 40) in the control group, making their 
fold changes uninterpretable. Therefore, they 
were excluded and 78 miRNAs only were an-
alyzed. According to the statistical analysis, 
32 differentially expressed miRNAs were 
found significant in the experimental cultures 
of all samples.  
 
Bioinformatics analysis 
Bioinformatics analysis was performed 
for the significantly dysregulated miRNAs 
obtained by statistical analysis. 
In the combinatorial method, the 32 dif-
ferentially expressed miRNAs submitted to 
the miRror Suite combinatorial miRNA target 
prediction tool resulted with 530 target genes, 
with cut off p-value 0.05. In the collective 
method, the total number of integrated pre-
dicted and validated targets obtained by miR-
Walk tool for the 32 miRNAs was 6594 target 
genes. These target genes were submitted for 
subsequent functional enrichment analysis.  
Functional enrichment analysis of the tar-
get genes obtained from the combinatorial 
miRNA target prediction analysis was done 
by submitting those predicted genes to DA-
VID and FunRich enrichment analysis tools 
for identifying the enriched biological pro-
cesses and pathways (Table 1). Among the bi-
ological processes which have shown statisti-
cal significance (P-value <0.05), there were 
several processes known to be involved in en-
dometriosis such as small GTPase mediated 
signal transduction including Ras and Rho 
protein signal transductions, ubiquitin cycle, 
histone modification, progesterone receptor 
signaling pathway and cellular morphogene-
sis during differentiation (Table 2). Also, 
there were various endometriosis related 
pathways that showed significant enrichment 
(P-value <0.05) for the 32 miRNA targets 
such as axon guidance, L1CAM interactions, 
hedgehog signaling events mediated by Gli 
proteins, VEGF and VEGFR signaling net-
work, IL4-mediated signaling events, and 
ErbB receptor signaling network (Figure 4A). 
 
Table 1: Significantly differentially expressed 
miRNAs 
Significantly deregu-
lated miRNAs 
Average Fold 
change 
P-value 
< 0.05 
hsa-mir-143-3p 55.720 < 0.001 
hsa -mir-15a-5p 358.679 < 0.001 
hsa -mir-186-5p 145867.788 < 0.001 
hsa -mir-27a-3p 40.455 0.001 
hsa -mir-27b-3p 98.238 0.001 
hsa -mir-29c-3p 32.249 0.001 
hsa -mir-30e-5p 60.316 0.001 
hsa -mir-125b-5p 12.261 0.002 
hsa -mir-195-5p 70.574 0.002 
hsa -mir-96-5p 0.207 0.004 
hsa -mir-30b-5p 12.321 0.005 
hsa -mir-22-3p 201.581 0.007 
hsa -mir-30c-5p 35.209 0.007 
hsa -mir-150-5p 0.125 0.008 
hsa mir-23b-3p 8.035 0.008 
hsa -mir-374a-5p 53.738 0.008 
hsa -mir-17-5p 74.875 0.009 
hsa -mir-185-5p 8.618 0.009 
hsa -mir-424-5p 22.594 0.014 
hsa -mir-20a-5p 197.908 0.015 
hsa -mir-29a-3p 151.545 0.015 
hsa -mir-23a-3p 5.390 0.017 
hsa -mir-106b-5p 26.974 0.021 
hsa -mir-144-3p 0.136 0.023 
hsa -mir-181a-5p 32.862 0.023 
hsa -mir-21-5p 21.269 0.024 
hsa -mir-103a-3p 10.616 0.028 
hsa -mir-19b-3p 321.448 0.029 
hsa -mir-93-5p 121.241 0.029 
hsa -mir-26b-5p 13.370 0.039 
hsa -mir-30a-5p 147.907 0.039 
hsa -mir-191-5p 38.489 0.045 
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Table 2: Enriched endometriosis related biological processes regulated by gene targets of the 32 dif-
ferentially expressed miRNAs  
Biological processes enriched by the 32 miRNAs target genes obtained by combinatorial method 
GO processes Biological Process P-value < 0.05 
GO:0007264 small GTPase mediated signal transduction 2.80E-05 
GO:0006512 ubiquitin cycle 0.002152192 
GO:0007266 Rho protein signal transduction 0.008030162 
GO:0016570 histone modification 0.010625 
GO:0007265 Ras protein signal transduction 0.027508388 
GO:0043966 histone H3 acetylation 0.032143879 
GO:0050847 progesterone receptor signaling pathway 0.042766723 
Funrich biological process Cellular morphogenesis during differentiation 0.030498474 
Biological processes enriched by the 32 miRNAs target genes obtained by collective method 
GO processes Biological Process Benjamini < 0.05
GO:0007049 cell cycle 5.41E-12 
GO:0006915 apoptosis 4.73E-09 
GO:0045597 positive regulation of cell differentiation 2.65E-07 
GO:0001944 vasculature development 2.66E-07 
GO:0016477 cell migration 1.04E-06 
GO:0007264 small GTPase mediated signal transduction 1.00E-05 
GO:0030155 regulation of cell adhesion 4.22E-05 
GO:0008283 cell proliferation 5.96E-05 
GO:0045596 negative regulation of cell differentiation 6.21E-05 
GO:0033554 cellular response to stress 7.71E-05 
GO:0000165 MAPKKK cascade 0.000101035 
GO:0043405 regulation of MAP kinase activity 0.000156933 
GO:0051674 localization of cell 0.000209518 
GO:0048729 tissue morphogenesis 0.000218238 
GO:0045165 cell fate commitment 0.000326222 
GO:0016049 cell growth 0.000415879 
GO:0006916 anti-apoptosis 0.000470742 
GO:0001666 response to hypoxia 0.000524477 
GO:0060284 regulation of cell development 0.000645819 
GO:0000904 cell morphogenesis involved in differentiation 0.000945717 
GO:0051270 regulation of cell motion 0.001751291 
GO:0007179 TGF β-receptor signaling pathway 0.001864809 
GO:0007265 Ras protein signal transduction 0.001955198 
GO:0010647 positive regulation of cell communication 0.002966888 
GO:0030518 steroid hormone receptor signaling pathway 0.004729534 
GO:0001525 angiogenesis 0.006732738 
GO:0006512 ubiquitin cycle 0.014264821 
GO:0034330 cell junction organization 0.016948406 
GO:0006979 response to oxidative stress 0.017139112 
GO:0048661 positive regulation of smooth muscle cell proliferation 0.027502572 
GO:0060429 epithelium development 0.029495403 
GO:0010717 regulation of epithelial to mesenchymal transition 0.036095114 
GO:0017145 stem cell division 0.036095114 
GO:0048545 response to steroid hormone stimulus 0.03634116 
GO:0042692 muscle cell differentiation 0.03890559 
GO:0030521 androgen receptor signaling pathway 0.041345041 
GO:0030036 actin cytoskeleton organization 0.036538482 
GO:0007173 epidermal growth factor receptor signaling pathway 0.044931881 
GO:0003006 reproductive developmental process 0.04518617 
GO:0010559 regulation of glycoprotein biosynthetic process 0.048524169 
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Meanwhile, the total target genes of the 32 
miRNAs obtained from the collective method 
underwent functional enrichment analysis for 
identifying the enriched biological processes 
and pathways using DAVID database. This 
analysis resulted in a plenty of enriched endo-
metriosis related biological processes and 
pathways with high enrichment statistical sig-
nificance (Benjamini value < 0.05). These bi-
ological processes involve nearly most of the 
key processes which are involved in endome-
triosis such as cell cycle, apoptosis, cell mi-
gration, positive regulation of cell differentia-
tion and proliferation, epithelium develop-
ment, vasculature development, angiogene-
sis, cell migration, regulation of cell motion, 
regulation of cell adhesion, positive regula-
tion of cell communication, cellular response 
to stress, response to hypoxia, MAPKKK cas-
cade and regulation of mitogen activated pro-
tein kinase (MAPK) activity, epidermal 
growth factor receptor (EGFR) signaling, re-
productive developmental process, response 
to steroid hormone stimulus, and others (Ta-
ble 2). 
Moreover, many significantly enriched 
pathways that are possibly involved in endo-
metriosis were identified through our analysis 
using the gene list of the collective method. 
These pathways include pathways in cancer, 
p53 signaling pathway, neurotrophin signal-
ing pathway, MAPK signaling pathway, ErbB 
signaling pathway, mTOR signaling pathway, 
focal adhesion, endometrial cancer, TGF-β 
signaling pathway, Ras Pathway, Wnt signal-
ing pathway, PI3K pathway, PDGF signaling 
pathway, GnRH signaling pathway, adherens 
junction, gap junction, axon guidance and 
others (Figure 4B).
 
 
Figure 4: Enriched endometriosis pathways versus –Log 10 P value for miRNA target genes of differ-
entially expressed miRNAs.  
The figure shows the functional pathways that are significantly enriched in response to miRNA dysreg-
ulation in endometriosis obtained by combinatorial method (P value < 0.05) (A) and collective method 
(Benjamini < 0.05) (B). 
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The common enriched endometriosis re-
lated biological processes between the two 
methods were small GTPase mediated signal 
transduction, Ras protein signal transduction, 
ubiquitin cycle, and cellular morphogenesis 
during differentiation. Whereas the common 
enriched pathways between both methods 
were axon guidance, ErbB signaling, and 
ubiquitin mediated proteolysis. 
 
DISCUSSION 
Endometriosis is a gynecological disease 
that causes socioeconomic burden compro-
mising women's quality of life and is a com-
mon cause of infertility. In the present study, 
we investigated the effect of the stressful 
pathogenic condition of endometriosis, repre-
sented in endometriotic serum, on human en-
dometrial mesenchymal stromal/stem cells 
(eMSCs) with regard to their miRNA expres-
sion. This study design was based on our pre-
vious observation which revealed that serum 
of women with endometriosis possibly har-
bors endometriosis inducing factor(s) (EIF) 
that can lead to the transformation of MSCs 
into endometrial like cells and glands in vitro 
(Rasheed et al., 2010; Azmy and Elgarf, 2012; 
Azmy et al., 2014). 
Treatment of human eMSC culture with 
the serum of severe endometriosis cases was 
found to affect the expression of certain miR-
NAs and in turn, their target genes that may 
play major roles in modulating cell functions 
and fate. We profiled the expression of 84 
well-characterized miRNAs in control and 
endometriotic serum treated eMSCs using hu-
man miFinder miRNA PCR array (MIHS-
001Z); a readymade miRNA panel designed 
to profile the expression of the most abun-
dantly expressed and best characterized miR-
NAs in the miRBase database. The complex 
role of each of these miRNAs in this panel, in 
different diseases, is still not completely de-
termined. Endometriotic serum treated eM-
SCs showed alterations in the expression of 
several analyzed miRNAs, thirty-two of 
which were significantly differentially ex-
pressed. The 32 significantly altered miRNAs 
were found to regulate 530 target genes de-
rived by miRror Suite combinatorial miRNA 
target prediction tool and 6594 target genes 
derived by miRWalk tool. Functional analysis 
of both gene lists revealed that they enrich 
signaling pathways and biological processes, 
corroborate known endometriosis associa-
tions in the literature. 
Human mesenchymal stem/stromal cells 
(hMSCs) are multipotent precursors, located 
throughout the adult body tissues, especially 
in those with stromal vascular fractions, and 
believed to be involved in maintenance and 
repair of tissues (Hass and Otte, 2012). MSCs 
in culture exhibit a preferential ability to ad-
here to plastic surfaces facilitating their isola-
tion (Jiang et al., 2002). Depending on this 
characteristic and by enzymatic processing 
for normal (endometriosis free) endometria, 
endometrial hMSCs were isolated and propa-
gated in the suitable growth conditions. Cop-
ing with previous studies (Kao et al., 2011), 
cells displayed the typical fibroblast-like mor-
phology and exerted high expansion potential. 
At early passages, cultures were challenged 
with either endometriotic or control serum 
conducting two culture sets; experimental and 
control. Morphological and proliferative al-
terations were specifically observed in cul-
tures exposed to endometriotic serum, reflect-
ing its possible impact on eMSC cultures.  
Among the potent epigenetic players that 
regulate most of the biological processes in-
volved in endometriosis pathogenesis are 
miRNAs (Mari-Alexandre et al., 2016). 
Moreover, miRNAs are key candidates in reg-
ulating stem cell fate through controlling dif-
ferent cellular actions as proliferation and dif-
ferentiation (Mathieu and Ruohola-Baker, 
2013). In our study, among the 32 signifi-
cantly dysregulated miRNAs, ten miRNAs; 
miRs-150, 23b, 106b, 17-5p, 20a, 29c, 125b, 
143, 23a and 21, were found to be repeatedly 
reported as endometriosis related miRNAs 
(Wei et al., 2015). Meanwhile, some of the re-
maining 22 aberrantly expressed miRNAs in 
our study were significantly dysregulated in 
endometriotic tissues in individual studies 
such as miRs- 19b, 22, 27b, 29a, 30a-5p, 30b, 
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30c, 103a, 191, 195 (Pan et al., 2007), miR-
424 (Ohlsson Teague et al., 2009), miRs-186 
and -93 (Filigheddu et al., 2010).  
Supporting to the endometriotic miRNA 
dysregulation that is reported here, several 
studies have introduced a number of miRNAs 
that were aberrantly expressed in stromal cells 
derived from endometriotic tissues, compared 
to those derived from eutopic or normal endo-
metria (Lin et al., 2012; Abe et al., 2013; Hsu 
et al., 2014; Okamoto et al., 2015). However 
some of these reports investigated miRNAs 
that were not enrolled in our panel such as 
miR-199a-5p (Hsu et al., 2014), and miR-210 
(Okamoto et al., 2015), others reported endo-
metriosis related dysregulation in some of 
miRNAs that were significantly dysregulated 
in the present work such as miR-20a (Lin et 
al., 2012), miR-424 and miR-181a (Abe et al., 
2013).  
Herein, 29 miRNAs out of our 32 differ-
entially dysregulated miRNAs were overex-
pressed, while three (miR-144-3p, 150-5p, 
96-5p) were down-expressed. Such expres-
sion direction for a number of miRNAs was 
different from some literature data. For exam-
ple, hsa-mir-20a was found to be downregu-
lated in endometriotic tissues, compared with 
normal or eutopic endometrium (Pan et al., 
2007; Ohlsson Teague et al., 2009; Filigheddu 
et al., 2010), however, coping with our study, 
it was reported upregulated in endometriotic 
stromal cell cultures (Lin et al., 2012). This 
might be contributed to our different ap-
proach, where we used endometriotic serum 
challenged eMSCs and not an endometriotic 
tissue as in most literature studies.  
In our study, we used two in silico analy-
sis tools for the differentially expressed miR-
NAs, obtained from the PCR array performed. 
These tools were miRror tool, which is a com-
binatorial miRNA target prediction algo-
rithm, and miRWalk tool, which provides 
both predicted and experimentally validated 
miRNA targets. The main purpose for using 
both tools was to have an integrative view of 
combinatorial and individual microRNAs in-
teractions and hence functions and pathways. 
Within each tool, we used the intersections of 
diverse prediction tools for microRNA targets 
to get the most assured targets and minimize 
false positives so that we can depend on these 
results to be used in functional enrichment 
analysis.  
Our obtained functional enrichment anal-
ysis results agree with several previous stud-
ies which have performed enrichment analy-
sis for differentially expressed miRNAs in en-
dometriotic samples (Ohlsson Teague et al., 
2009; Filigheddu et al., 2010; Hawkins et al., 
2011; Aznaurova et al., 2014; Wei et al., 
2015). The obtained biological processes and 
pathways belong nearly to most of the key 
cellular functions that take part in endometri-
osis pathogenesis. Among these processes are 
cell cycle and its related processes such as 
apoptosis, cell death and proliferation; cell 
differentiation and epithelium development 
(Ohlsson Teague et al., 2009; Giudice et al., 
2012; Aznaurova et al., 2014); angiogenesis 
and related processes including vasculature 
development (Rocha et al., 2013), VEGF and 
VEGFR signaling network (Donnez et al., 
1998); cell migration and regulation of cell 
motion (Witz, 2003); cell adhesion and re-
lated actions such as regulation of cell adhe-
sion (Witz, 2003), L1CAM interactions 
(Finas et al., 2008), positive regulation of cell 
communication (Zhang et al., 2015), focal ad-
hesion (Mu et al., 2008), adherens junction 
and gap junction (Giudice et al., 2012); cellu-
lar response including response to stress, re-
sponse to hypoxia (Gupta et al., 2006) and re-
sponse to steroid hormone stimulus (Giudice 
et al., 2012). 
In addition, several signaling pathways 
that play crucial roles in most endometriosis 
cellular processes were found to be enriched 
in our analysis, such as MAPK signaling path-
way, MAPKKK cascade, regulation of 
MAPK activity (Santulli et al., 2015); EGFR 
signaling (Huang and Yeh, 1994; Ohlsson 
Teague et al., 2009); mTOR signaling path-
way (Choi et al., 2014); TGF-β signaling 
pathway (Aznaurova et al., 2014); Wnt sig-
naling pathway (Matsuzaki et al., 2014); PI3K 
pathway (Giudice et al., 2012); PDGF signal-
ing pathway (Aznaurova et al., 2014); p53 
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signaling pathway (Giudice et al., 2012), and 
hedgehog signaling events mediated by Gli 
proteins (Jeong, 2014). Moreover, pathways 
in cancer and endometrial cancer (Giudice et 
al., 2012), were among the obtained enriched 
pathways that are possibly involved in endo-
metriosis as it was deduced that cancer related 
pathways were also found enriched in endo-
metriosis (Wei et al., 2015). Other endometri-
osis related pathways were enriched in our 
analysis as GnRH signaling pathway (Weng 
et al., 2014), progesterone receptor signaling 
pathway (Wetendorf and DeMayo, 2014), 
neurotrophin signaling pathway (Borghese et 
al., 2010), histone modification (Monteiro et 
al., 2014), and IL4-mediated signaling events 
(OuYang et al., 2008).  
Importantly, our 2 methods of bioinfor-
matics analysis (combinatorial and collective) 
revealed a group of endometriosis associated 
biological processes and pathways which 
were commonly enriched by both ways and 
consequently we considered them the most 
important endometriosis related functional 
events that take place in our serum treated 
cells. Among the commonly enriched endo-
metriosis related biological processes were 
“small GTPases mediated signal transduc-
tion”, and “Ras (a GTPase) protein signal 
transduction”. Small GTPases are a large 
family of monomeric proteins that bind and 
hydrolyse GTP to GDP. They comprise sev-
eral super families such as Ras, Rho and Rac 
(Goitre et al., 2014). The Ras GTPases super-
family members are the most famous mem-
bers of the small GTPases family. They act as 
regulators of cell growth, differentiation, and 
survival (Ohlsson Teague et al., 2009). Ras 
network was found to be one of the essential 
molecular networks mediating the cellular 
and molecular crosstalk between endometrial 
and peritoneal tissues (Ohlsson Teague et al., 
2009). Therefore, these signal transduction 
processes play important roles in endometrio-
sis development. In addition, ubiquitin cycle 
and ubiquitin mediated proteolysis were com-
monly obtained from our both methods of 
analysis. Previously, ubiquitin was found to 
be highly expressed in endometriotic cells 
where it was proposed to be responsible for 
the survival of ectopic stromal cells. It was 
deduced that its expression may contribute to 
reduced sensitivity of ectopic endometriotic 
cells to apoptosis and consequently the devel-
opment of ectopic lesions (Ilad et al., 2004). 
Another common biological process obtained 
from the 2 bioinformatics analysis methods 
was “cellular morphogenesis during differen-
tiation”. Differentiation is one of the crucial 
processes through which stem cells act in the 
pathogenesis of endometriosis. Morphogene-
sis, which is a part of the differentiation pro-
cess, is the mechanism through which tissues, 
such as vascular and glandular tissues, ac-
quire their shapes and completely develop in-
side the endometriotic lesions (Sasson and 
Taylor, 2008; Vasquez et al., 2016). 
Moreover, two important endometriosis 
related pathways were commonly enriched by 
our both methods of analysis, which are ErbB 
signaling and axon guidance. ErbB signaling 
pathway has been detected previously as a 
significant endometriosis related pathway 
(Huang and Yeh, 1994; Filigheddu et al., 
2010). ERBB/HER is a family of four trans-
membrane receptor tyrosine kinases includ-
ing epidermal HER1/ERBB1 (also named as 
epidermal growth factor receptor), HER2/ 
ERBB2, HER3/ERBB3 and HER4/ ERBB4, 
couples binding of extracellular growth factor 
ligands to intracellular signaling pathways 
(Arteaga and Engelman, 2014), and involved 
in different essential endometriosis related 
cellular processes such as proliferation, dif-
ferentiation, cell motility, migration, adhesion 
and survival (Figure 5) (Kanehisa Laborator-
ies, 2016). Axon guidance is one of the novel 
pathways found to be familiar to endometrio-
sis (Wei et al., 2015). It was deduced that 
axon guidance is one of the strongly predicted 
pathways to be relevant for endometriosis. 
Although it may seem that axon guidance is 
not related to the endometriosis pathology, 
however it was found that nerves and blood 
vessels are closely related physically and in 
their morphogenesis and that there are com-
mon molecules involved in both axon guid-
ance and angiogenesis (Filigheddu et al., 
2010). 
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Figure 5: ErbB signaling pathway from Kyoto encyclopedia of genes and genomes.  
ErbB signaling pathway was predicted to be relevant to endometriosis. It is a key pathway that is in-
volved in different essential endometriosis related cellular processes such as proliferation, differentia-
tion, cell motility, migration, adhesion and survival (http://www.genome.jp/kegg-bin/show_path-
way?hsa04012). 
 
 
 
CONCLUSION 
The stressful micro milieu of serum de-
rived from severe endometriosis cases can in-
duce significant epigenetic changes in 
miRNA expression level in endometrial mes-
enchymal stem/stromal cells derived from 
non-endometriotic donors. This in turn affects 
their target genes that may play major roles in 
modulating the stem cell functions and fate. 
This in vitro proposed scenario may resemble 
the in vivo one, supporting MSC relevance to 
disease progression. Our findings provide 
new insights for miRNA based therapies tar-
geting eMSCs of women affected by this de-
bilitating condition. 
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